Santen Pharmaceutical. (SZD.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.1
0.12
0.15
0.17

Details

Expected EPS
0.13971680699042405
Actual EPS
0.1500076333593
Surprise EPS
0.01
Surprise Percent
+7.37%

Description

Santen Pharmaceutical. (SZD.F) has reported earnings of 0.1500076333593 per share for Q4 2024.

0 Comments

Share your thoughts